期刊文献+

食管鳞癌中CDC2、MCM2的表达及其临床意义 被引量:1

Expressions of MCM2 and CDC2 in esophageal squamous cell carcinoma and their clinical significance
下载PDF
导出
摘要 目的:检测细胞分裂周期2(CDC2)、微小染色体维持蛋白2(MCM2)在食管鳞癌组织中的表达情况,探讨其与食管鳞癌临床病理参数的关系以及在食管鳞癌发生、发展中的作用。方法:应用免疫组化Elivision法检测90例食管鳞癌患者癌组织、28例食管鳞癌患者癌旁正常上皮组织及16例重度不典型增生患者上皮组织中CDC2、MCM2的表达情况。结果:CDC2、MCM2在食管鳞癌组织中的表达明显高于食管癌旁正常上皮、重度不典型增生组织(P<0.01);食管鳞癌组织中CDC2的表达程度与其临床分期有关(P<0.05),MCM2的表达与其分化程度和淋巴结转移均有一定关系(P<0.05);食管鳞癌组织中CDC2和MCM2表达呈正相关关系(P<0.05)。结论:CDC2、MCM2在细胞周期调控中起决定性作用,两者相互协调共同促进了食管鳞癌的发生、发展,可作为临床早期诊断的重要指标。 Objective:To study the expression of CDC2 and MCM2 in human esophageal squamous cell carcinoma(ESCC),and to investigate their relationship with clinicopathological parameters and their role in the genesis and development of ESCC.Methods:The expressions of CDC2 and MCM2 in 90 cases of human esophageal squamous cell carcinoma,28 cases of adjacent normal tissues and 16 cases of severe dysplasia were determined using Elivision immunohistochemical technique.Results:The positive rates of expressions of CDC2 and MCM2 in ESCC were higher than that in the normal tissue(P〈0.01);the expression of CDC2 was associated with the clinical staging in ESCC(P〈0.05).The expression of MCM2 was associated with the differentiation grade and metastasis of lymph nodes in ESCC(P〈0.05).And there was negatively correlation between CDC2 and MCM2.Conclusions: CDC2 and MCM2 play a crucial role in cell cycle regulation.They together promote the genesis and development of ESCC,and may serve as an important index in early diagnosis of ESCC.
出处 《蚌埠医学院学报》 CAS 2009年第10期861-864,共4页 Journal of Bengbu Medical College
基金 安徽省自然科学基金资助项目(0704130890) 安徽省教育厅自然科学研究资助项目(2006kj343B)
关键词 食管肿瘤 细胞分裂周期2 微小染色体维持蛋白2 esophageal neoplasms cell division cycle 2 minichromosome maintenance protein 2
  • 相关文献

参考文献1

二级参考文献17

  • 1Spechler SJ. Barrett's esophagus and esophageal adenocarcinorna:pathogenesis, diagnosis, and therapy. Med Clin North Am 2002;86:1423-1445.
  • 2Reynolds JC, Rahimi P, Hirschl D. Barrett's esophagus: clinical characteristics. Gastroenterol Clin North Am 2002; 31:441-460.
  • 3Cossentino MJ, Wong RK. Barrett's esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis 2003; 14:128-135.
  • 4Younes M, Henson DE, Ertan A, Miller CC. Incidence and survival trends of esophageal carcinoma in the United States:racial and gender differences between histological type. Scand J Gastroenterol 2002; 37:1359-1365.
  • 5Vega KJ, Jamal MM. Changing pattern of esophageal cancer incidence in New Mexico. Am J Gastroenterol 2000; 95:2352-2356.
  • 6Li K, Yu P. Food groups and risk of esophageal cancer in Chaoshan region of China: a high-risk area of esophageal cancer.Cancer Invest 2003; 21:237-240.
  • 7Klimstra DS. Pathologic prognostic factors in esophageal carcinoma. Semin Oncol 1994; 21:425-430.
  • 8Stathopoulos GP, Tsiaras N. Epidemiology and pathologenesis of esophageal cancer management and its controversial results(review). Oncol Rep 2003; 10:449-454.
  • 9Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, Liu SZ, Duan WJ.Epidemiology of gastroenterologic cancer in Henan Province,China. World J Gastroenterol 2003; 9:2400-2403.
  • 10Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994; 21:403-410.

共引文献21

同被引文献12

  • 1Sherr CJ.Cancer cell cycle[J].Science,1996,274(5293):1672-1677.
  • 2Lohrish C,Piccart M.An overview of HER-2[J].Semin Oncol,2001,28(6):3-11.
  • 3Merrick KA,Larochelle S,Zhang C,et al.Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells[J].Mol Cell,2008,32(5):662-672.
  • 4Lu Q,Zhang P,Zhang X,et al.Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer[J].Int J Mol Med,2009,24(6):773-780.
  • 5Samuel T,Weber HO,Funk JO.Linking DNA damage to cell cycle checkpoints[J].Cell Cycle,2002,1(3):16-28.
  • 6Gao CY,Bassnett S,Zelenka PS,et al.CyclinB,p34cdc2,and H1-kinase activity in terminally differentiating lens fiber cells[J].Dev Biol,1995,169(1):185-194.
  • 7Xu N,Chang DC.Different thresholds of MPF inactivation are responsible for controlling different mitotic events in mammalian cell division[J].Cell Cycle,2007,6(13):1639-1645.
  • 8Km DH.Prognostic implications of cyclinB1,p34cdc2,p27kpi1 and p53 expression in gastric cancer[J].Yonsei Med J,2007,48 (4):694-700.
  • 9Yang CJ,Wang CS,Hung JY,et al.Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model[J].Lung Cancer,2009,66(2):162-168.
  • 10Kawamoto H,Koizumi H,Uchikoshi T.Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in non-malignant and malignant human breast lesions immunocytochemical and quantitative image analyses[J].Am J Pathol,1997,150(1):15-23.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部